- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
South San Francisco Today
By the People, for the People
Prosight Management LP Buys New Stake in Twist Bioscience
Hedge fund purchases 75,000 shares of biotech company in Q3
Mar. 14, 2026 at 11:09am
Got story updates? Submit your updates here. ›
Prosight Management LP, a hedge fund, purchased a new stake of 75,000 shares in Twist Bioscience Corporation (NASDAQ:TWST) during the third quarter of 2026, according to a recent SEC filing. The stake was valued at approximately $2.11 million, representing 0.12% ownership of the biotech company.
Why it matters
Twist Bioscience is a prominent synthetic biology company known for its innovative DNA synthesis platform. The purchase of a new stake by Prosight Management, a respected hedge fund, signals potential investor confidence in Twist's growth prospects and technology.
The details
According to the 13F filing, Prosight Management LP acquired 75,000 shares of Twist Bioscience in the third quarter. This new position represents 0.12% of the company's outstanding shares. Other notable investors who have increased their stakes in Twist Bioscience during the quarter include Campbell & CO Investment Adviser LLC, Thrivent Financial for Lutherans, Baillie Gifford & Co., and the New York State Common Retirement Fund.
- Prosight Management LP purchased the new stake in Twist Bioscience during the third quarter of 2026.
The players
Prosight Management LP
A hedge fund that purchased a new stake in Twist Bioscience Corporation.
Twist Bioscience Corporation
A synthetic biology company specializing in the development and commercialization of DNA-based products and solutions.
The takeaway
The purchase of a new stake in Twist Bioscience by Prosight Management LP suggests growing investor interest in the company's innovative DNA synthesis technology and its potential for future growth in the synthetic biology market.
